MSF frequently publishes updates, press releases, and other forms of communication about its work in roughly 70 countries around the world. See the list below for the most recent updates or search by location, topic, or year.

Have you heard about the Trans-Pacific Trade Pact (TPP)? No? You're not alone. Negotiations are being conducted in secret, behind closed doors. But it's slated to become the most harmful trade agreement ever for access to medicines. It's not too late to act. Ask countries negotiating the TPP to protect people in developing countries. Click here for details.

More >

Doctors Without Borders/Médecins Sans Frontières (MSF) staff and supporters rallied outside the offices of the European Commission on November 8, before delivering an open letter of protest against ongoing trade talks between the European Union and India that could damage access to affordable medicines. The provisions in the free trade agreement under discussion could seriously impede generic medicines producers in India from delivering more affordable and quality generic versions of medicines for people in developing countries. MSF itself could not carry out much of its medical humanitarian work without access to these drugs. Support MSF's campaign 'Europe! Hands Off Our Medicine!'

More >

Generic versions of antiretrovirals, or ARVs, that cost a fraction of the price of brand medicines make it possible for MSF to treat 160,000 people living with HIV around the world. Eighty percent of the ARVs we use come from India, and millions of others in developing countries depend on India-made generics as well. But the European Commission has begun directing its trade policies in a way that could stamp out the production of lifesaving generics in India. MSF has launched a global public campaign to tell Europe to back off, and to honor its commitments to global health.

More >